Not Yet RecruitingPhase 4

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

400 participantsStarted 2025-05-01

Plain-language summary

In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor Exclusion Criteria: * pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides

What they're measuring

maternal infections

Timeframe: birth to 6 weeks post partum

Trial details

NCT IDNCT06958146

SponsorArmed Forces Hospital, Pakistan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Maternal and Neonatal Sepsis trials